NDC 85512-5086-03: Phentolamine Mesylate 1 g/g Powder, 10 g Bag
This is a package of 10 g of Phentolamine Mesylate 1 g/g Powder from Qingdao Qinzeyuan Biotechnology Co., Ltd., first listed with the FDA Jan 2025 and currently FDA-listed.
NDC database record
One package, one record: these facts belong to NDC 85512-5086-3 alone.
- Record
- FDA NDC Directory package listing · Bulk ingredient
- Code segments
- 85512 labeler · 5086 product · 3 package
- Package marketed since
- Jan 1, 2025
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 8551250863 4
- FDA record last changed
- Aug 27, 2026
Other active recalls for Phentolamine Mesylate (different manufacturers) — 1 · tap to view
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
This is a bulk powder of phentolamine mesylate, a pharmaceutical substance supplied for use by licensed manufacturers and compounders in preparing finished medicines. Phentolamine mesylate is typically used in injectable products designed to treat acute blood pressure elevation, particularly in cases of hypertensive crisis or during surgery. This listing is the drug substance itself, not a finished consumer product; it is intended only for professional pharmaceutical preparation and compounding.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 85512-5086-01 85512-5086-1 Main listing | 1 g in 1 BOTTLE | — | — | Active |
| 85512-5086-02 85512-5086-2 | 5 g in 1 BAG | — | — | Active |
| 85512-5086-03 You're viewing this | 10 g in 1 BAG | — | — | Active |
| 85512-5086-04 85512-5086-4 | 50 g in 1 BAG | — | — | Active |
| 85512-5086-05 85512-5086-5 | 100 g in 1 BAG | — | — | Active |
| 85512-5086-06 85512-5086-6 | 500 g in 1 BAG | — | — | Active |
| 85512-5086-07 85512-5086-7 | 1000 g in 1 BAG | — | — | Active |
You're viewing one of 7 pack sizes for this product.
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 85512-5086-01?
What NDC number is used to bill for this package of Phentolamine Mesylate 1 g/g Powder?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Phentolamine Mesylate 1 g/g 49452-5217-05 | Spectrum | 5 g | — | — | FDA listed | — |
| Phentolamine Mesylate 1 g/g 73377-0312-01 | AX | 10 g | — | — | FDA listed | — |
| Phentolamine Mesylate 1 g/g 70859-0100-01 | NuCare | 1 g | — | — | FDA listed | — |
| Phentolamine Mesylate 1 g/g 51927-2669-00 | Professional | 1 g | — | — | FDA listed | — |
| Phentolamine Mesylate 1 g/g 62991-1108-01 | LETCO | 1 g | — | — | FDA listed | — |
| Phentolamine Mesylate 1 g/g 71052-0285-00 | DARMERICA, | 1 g | — | — | FDA listed | — |
| Phentolamine Mesylate 1 g/g 60592-0602-10 | KALCHEM | 1000 g | — | — | FDA listed | — |
| Phentolamine Mesylate 1 g/g 73212-0028-01 | Qingdao | 1 g | — | — | FDA listed | — |
| Phentolamine Mesylate 1 g/gthis 85512-5086-03 | Qingdao | 10 g | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Qingdao Qinzeyuan Biotechnology Co., Ltd. labeler code 85512
- Procaine Hydrochloride 1 g/g Powder NDC 85512-3148-1
- Choline Chloride 1 g/g Powder NDC 85512-3152-1
- OS-01 4-(3-(DIMETHYLAMINO)PROPYLSULFANYLCARBONYL-(4-OXO-4-PENTADECAN-8-YLOXYBUTYL)AMINO)BUTANOATE 1 g/g Powder NDC 85512-3167-1
- SLU-PP-332 1 g/g Powder NDC 85512-3202-1
- Aminophylline 1 g/g Powder NDC 85512-4064-1
- Hydroxypropyl Betadex 1 g/g Powder NDC 85512-5074-1
- Tropicamide 1 g/g Powder NDC 85512-5474-1
- Betahistine Hydrochloride 1 g/g Powder NDC 85512-5504-1
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
This is a bulk ingredient listing — not a retail prescription package
Phentolamine Mesylate 1 g/g POWDER is listed with FDA as a bulk ingredient (a drug substance supplied for further manufacturing or licensed pharmacy compounding). It is not a finished product a patient would receive at a retail pharmacy, so consumer-style information — a patient label, retail pricing, package photos — generally does not exist for this NDC. The listing identifies the substance and package for supply-chain and regulatory purposes.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |